# Corbus Pharmaceuticals Holdings, Inc.: filings

CRBP · Nasdaq · CIK 1595097 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crbp.md) · [Financials](/companies/crbp/financials.md) · [Filings](/companies/crbp/filings.md) · [Insiders](/companies/crbp/insiders.md)

## Reports and events: 250 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 309, 8-K 178, SC 13G/A 44, 10-Q 36, 3 27, SC 13G 21, 424B5 16, 144 14, CORRESP 13, DEF 14A 13, S-8 13, 10-K 12, 424B3 12, DEFA14A 12, UPLOAD 12, EFFECT 9, SCHEDULE 13G/A 7, 8-K/A 6, S-3 6, CT ORDER 5, ARS 4, PRE 14A 4, D 3, SCHEDULE 13G 3, 4/A 2, 8-A12G 2, POS AM 2, S-1/A 2, S-3/A 2, 10-K/A 1, 10-Q/A 1, 5 1, 8-A12B 1, CERTNAS 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 10:27 ET | [8-K](/filings/0001193125-26-422437.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422437 |
| 2026-09-14 | 07:06 ET | [8-K](/filings/0001193125-26-389829.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389829 |
| 2026-08-06 | 16:35 ET | [10-Q](/filings/0001193125-26-338274.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338274 |
| 2026-08-06 | 08:15 ET | [8-K](/filings/0001193125-26-336864.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-336864 |
| 2026-07-06 | 08:15 ET | [8-K](/filings/0001193125-26-295622.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-295622 |
| 2026-05-26 | 08:56 ET | [8-K](/filings/0001193125-26-238059.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-238059 |
| 2026-05-21 | 08:15 ET | [8-K](/filings/0001193125-26-233507.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-233507 |
| 2026-05-14 | 08:15 ET | [8-K](/filings/0001193125-26-222890.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-222890 |
| 2026-05-12 | 16:50 ET | [10-Q](/filings/0001193125-26-219707.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219707 |
| 2026-05-12 | 08:15 ET | [8-K](/filings/0001193125-26-218250.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-218250 |
| 2026-04-16 | 16:19 ET | [8-K](/filings/0001193125-26-159062.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-159062 |
| 2026-04-14 | 08:15 ET | [8-K](/filings/0001193125-26-153923.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-153923 |
| 2026-04-07 | 08:15 ET | [8-K](/filings/0001193125-26-144588.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-144588 |
| 2026-04-02 | 16:47 ET | [DEF 14A](/filings/0001193125-26-140363.md) | Proxy statement, period 2026-04-01 | 0001193125-26-140363 |
| 2026-03-09 | 16:16 ET | [10-K](/filings/0001193125-26-098530.md) | Annual report, period 2025-12-31 | 0001193125-26-098530 |
| 2026-03-09 | 07:43 ET | [8-K](/filings/0001193125-26-097582.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097582 |
| 2026-02-25 | 07:45 ET | [8-K](/filings/0001193125-26-068566.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-068566 |
| 2026-01-12 | 07:26 ET | [8-K](/filings/0001193125-26-009758.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009758 |
| 2025-12-18 | 16:05 ET | [8-K](/filings/0001193125-25-324796.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-324796 |
| 2025-12-11 | 07:22 ET | [8-K](/filings/0001193125-25-315039.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-315039 |
| 2025-11-12 | 16:30 ET | [10-Q](/filings/0001193125-25-277748.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277748 |
| 2025-11-12 | 08:14 ET | [8-K](/filings/0001193125-25-276062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-276062 |
| 2025-11-03 | 08:02 ET | [8-K](/filings/0001193125-25-261722.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-261722 |
| 2025-10-30 | 16:34 ET | [8-K](/filings/0001193125-25-258692.md) | 8.01 Other events | 0001193125-25-258692 |
| 2025-10-20 | 07:53 ET | [8-K](/filings/0001193125-25-243046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-243046 |
| 2025-09-16 | 08:45 ET | [8-K](/filings/0001193125-25-204389.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-204389 |
| 2025-08-05 | 16:30 ET | [10-Q](/filings/0000950170-25-103118.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103118 |
| 2025-08-05 | 09:00 ET | [8-K](/filings/0000950170-25-102447.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-102447 |
| 2025-05-19 | 08:30 ET | [8-K](/filings/0000950170-25-073967.md) | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-25-073967 |
| 2025-05-06 | 16:21 ET | [10-Q](/filings/0000950170-25-064507.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064507 |
| 2025-05-06 | 08:30 ET | [8-K](/filings/0000950170-25-063990.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-063990 |
| 2025-04-01 | 16:35 ET | [DEF 14A](/filings/0000950170-25-048603.md) | Proxy statement, period 2025-05-15 | 0000950170-25-048603 |
| 2025-03-21 | 16:40 ET | [8-K](/filings/0000950170-25-043276.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-043276 |
| 2025-03-18 | 16:30 ET | [8-K](/filings/0000950170-25-041254.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-041254 |
| 2025-03-11 | 17:24 ET | [10-K](/filings/0000950170-25-037335.md) | Annual report, period 2024-12-31 | 0000950170-25-037335 |
| 2025-03-11 | 08:30 ET | [8-K](/filings/0000950170-25-036838.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-036838 |
| 2025-02-14 | 08:05 ET | [8-K](/filings/0000950170-25-020424.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-020424 |
| 2024-12-03 | 08:00 ET | [8-K](/filings/0000950170-24-132458.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-132458 |
| 2024-11-15 | 16:36 ET | [8-K](/filings/0000950170-24-127644.md) | 8.01 Other events | 0000950170-24-127644 |
| 2024-11-07 | 16:58 ET | [10-Q](/filings/0000950170-24-123486.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123486 |
| 2024-11-07 | 08:41 ET | [8-K](/filings/0000950170-24-122839.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122839 |
| 2024-11-04 | 07:51 ET | [8-K](/filings/0000950170-24-120289.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-120289 |
| 2024-09-03 | 16:52 ET | [8-K](/filings/0000950170-24-102878.md) | 8.01 Other events | 0000950170-24-102878 |
| 2024-08-20 | 08:15 ET | [8-K](/filings/0000950170-24-098861.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-098861 |
| 2024-08-06 | 16:42 ET | [8-K](/filings/0000950170-24-091931.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-091931 |
| 2024-08-06 | 16:38 ET | [10-Q](/filings/0000950170-24-091922.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091922 |
| 2024-08-06 | 08:15 ET | [8-K](/filings/0000950170-24-091219.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-091219 |
| 2024-06-17 | 09:21 ET | [8-K](/filings/0000950170-24-074032.md) | 8.01 Other events | 0000950170-24-074032 |
| 2024-06-03 | 07:08 ET | [8-K](/filings/0000950170-24-067651.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-067651 |
| 2024-05-20 | 16:30 ET | [8-K](/filings/0000950170-24-062436.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-062436 |

Page 1 of 5. [Older](/companies/crbp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 11:04 ET. No prices; not investment advice.